BioSpace News Archive

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in the William Blair 43rd Annual Growth Stock Conference.

RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that it has received a written notification from the Nasdaq Stock Market LLC dated May 9, 2023 indicating that the Company is not in compliance with the minimum Market Value of Publicly Held Shares set forth in the Nasdaq Rules for continued Nasdaq listing.

Lucid Diagnostics Inc. today provided a business update for the Company and presented financial results for the three months ended March 31, 2023.

Eisai Co., Ltd. and Biogen Inc. announced today that Health Canada has accepted a New Drug Submission (NDS) for lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril* antibody, for the treatment of early Alzheimer’s disease (mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD dementia) with confirmed amyloid pathology in the brain.

Clinical Laserthermia Systems Americas, Inc., a leading provider of office-based, focal laser ablation systems for urologists, announced that AVANT Concierge Urology of Winter Garden, FL, has safely treated its first patients with low-to- intermediate risk prostate cancer using its TRANBERG™ Thermal Therapy System.